Abstract
The announcement and publication of the second National Acute Spinal Cord Injury Study (NASCIS II) project's findings regarding the role of high dose methylprednisolone in improving neurological outcomes following acute traumatic spinal cord injury generated widespread excitement and interest. To determine the association between this interest and actual use and implementation of the protocol, Colorado's comprehensive population-based spinal cord injury surveillance data were examined. The medical records of 218 SCI survivors injured between May 1, 1990 and December 31, 1991, and of 145 persons spinal cord injured 2 years later, during 1993, were reviewed to determine the rapidity and extent of NASCIS II implementation by Colorado's hospitals, factors associated with use and non-use of the protocol, changing usage trends over time, and the short term neurological outcomes of patients who received the protocol. Clear documentation of the protocol's usage was present for only 46% of the reported patients' medical records in 1990-91, and 61% in 1993. Small, emergency triage facilities were significantly more likely to use the protocol than larger acute care hospitals, and patients with initially incomplete injuries were less likely to receive the drug. There were no significant differences in neurological outcomes, using the Frankel classification system, between those who received the protocol and those who did not. The limitations and implications of these findings are discussed.
Similar content being viewed by others
Article PDF
References
Bracken M B et al. A randomized, controlled trial of methylpred- nisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 1990; 322: 1405–1411.
Hanigan W C, Anderson R J . Commentary of NASCIS-2. J Spinal Disord 1992; 5: 125–131.
Walker M D . Clinical Alert. National Institute on Neurological Disorders and Stroke. Public Health Services: National Institute of Health. US Department of Health & Human Services: Bethesda, Maryland, 1990.
Weiss R . Drug reduces paralysis after spinal injury. Science News 1990; 137: 212.
Leary W . Treatment is said to reduce disability from spinal injury. New York Times, March 31, 1990.
World Health Organization. World Health Organization Inter national Classification of Impairments, Disabilities and Handi caps: a Manual of Classification Relating to the Consequences of Disease. World Health Organization: Geneva, 1980.
Colorado Department of Health. 1993 Annual Report of the Spinal Cord Injury Early Notification System. Colorado Depart ment of Transportation Printing Office: Denver, Colorado, 1994.
Frankel H et al. The value of postural reduction in the initial management of closed injuries to the spine with paraplegia and tetraplegia. Paraplegia 1969; 7: 179–192.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gerhart, K., Johnson, R., Menconi, J. et al. Utilization and effectiveness of methylprednisolone in a population-based sample of spinal cord injured persons. Spinal Cord 33, 316–321 (1995). https://doi.org/10.1038/sc.1995.71
Issue Date:
DOI: https://doi.org/10.1038/sc.1995.71
Keywords
This article is cited by
-
A review: the role of high dose methylprednisolone in spinal cord trauma in children
Pediatric Surgery International (2012)